Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
TWIN DISC INCTwin Disc Reports 9.7% Net Sales Increase in Q1 Fiscal 2026
X4 Pharmaceuticals, IncX4 Pharmaceuticals Reports $1.8 Million Revenue in Q3 2025, Net Loss Improves
ONE STOP SYSTEMS, INC.One Stop Systems Reports 36.9% Revenue Growth and Net Income Turnaround in Latest Quarter
VERACYTE, INC.Veracyte Reports 14% Revenue Growth to $131.9 Million in Q3 2025
SmartRent, Inc.SmartRent Reports 11% Revenue Decline and $6.3 Million Net Loss in Q3 2025
MANNKIND CORPMannKind Corporation Reports 17% Revenue Growth to $82.1 Million in Latest Quarter
Praxis Precision Medicines, Inc.Praxis Precision Medicines Reports $73.9 Million Net Loss in Q3 2025
Centuri Holdings, Inc.Centuri Holdings Reports 18.1% Revenue Growth to $850M in Latest Quarter
Burford Capital LtdBurford Capital Reports 72% Revenue Decline in Q3 2025
NewAmsterdam Pharma Co N.V.NewAmsterdam Pharma Reports 99% Revenue Decline and Increased Operating Losses in Q3 2025
Zeta Global Holdings Corp.Zeta Global Reports 25.7% Revenue Growth to $337.2 Million in Latest Quarter
Viridian Therapeutics, Inc.\DEViridian Therapeutics Reports $70.6M Revenue in Q3 2025, Net Loss Decreases to $34.6M
VISHAY INTERTECHNOLOGY INCVishay Intertechnology Reports 7.5% Revenue Growth but Net Loss in Latest Quarter
Rapid7, Inc.Rapid7 Reports Q3 2025 Revenue of $217.96 Million, Net Income Declines
Lexeo Therapeutics, Inc.Lexeo Therapeutics Reports Q3 2025 Financial Results with Improved Net Loss
Shutterstock, Inc.Shutterstock Reports 4% Revenue Growth to $260.1 Million in Q3 2025
Latham Group, Inc.Latham Group Reports 7.6% Increase in Net Sales and Improved Net Income for Fiscal Quarter Ended September 27, 2025
Centessa Pharmaceuticals plcCentessa Pharmaceuticals Reports $54.9 Million Net Loss in Q3 2025
Compass Therapeutics, Inc.Compass Therapeutics Reports $14.3 Million Net Loss in Q3 2025, Total Assets Rise to $231.3 Million
Sionna Therapeutics, Inc.Sionna Therapeutics Reports $54.8 Million Net Loss for Nine Months Ending September 30, 2025
Unity Software Inc.Unity Software Inc. Reports Q3 2025 Revenue of $470.6 Million, Net Loss of $126.8 Million
Upstream Bio, Inc.Upstream Bio Reports $33.7 Million Net Loss in Q3 2025, Increased R&D Expenses
Lineage, Inc.Lineage, Inc. Reports Q3 2025 Revenue of $1.377 Billion, Net Loss of $100 Million
Boundless Bio, Inc.Boundless Bio Reports Q3 2025 Financial Results with Reduced Net Loss
Dine Brands Global, Inc.Dine Brands Global Reports Q3 2025 Revenue of $216.2 Million, Net Income Declines